{"id":15592,"date":"2019-10-04T11:29:01","date_gmt":"2019-10-04T09:29:01","guid":{"rendered":"http:\/\/fefac.cat\/empresarial\/?p=15592"},"modified":"2019-10-04T11:35:08","modified_gmt":"2019-10-04T09:35:08","slug":"estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional","status":"publish","type":"post","link":"https:\/\/fefac.cat\/empresarial\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\/","title":{"rendered":"Dos estudis alerten que els f\u00e0rmacs m\u00e9s cars no sempre ofereixen un benefici addicional en proporci\u00f3 al seu elevat cost"},"content":{"rendered":"\n<p>El doctor Josep Tabernero, cap del servei d\u2019Oncologia M\u00e8dica de l\u2019Hospital de la Vall d\u2019Hebron de Barcelona, va explicar,  en el marc del Congr\u00e9s anual de la Societat Europea d&#8217;Oncologia M\u00e8dica (ESMO) celebrat a Barcelona, alguns dels principals estudis que s&#8217;han donat a con\u00e8ixer durant el congr\u00e9s. Va posart posar el focus sobre l\u2019especial atenci\u00f3 que s\u2019est\u00e0 prestant des de l\u2019ESMO al necessari equilibri entre el cost dels nous tractaments oncol\u00f2gics i els beneficis reals que aporten.<\/p>\n\n\n\n<p>En aquest sentit, dos estudis que s\u2019han presentat en aquest ESMO 2019\naborden aquesta q\u00fcesti\u00f3, i les seves conclusions indiquen que sovint aquests\ntractaments tenen un esc\u00e0s valor afegit respecte a altres tractaments m\u00e9s\nantics i m\u00e9s econ\u00f2mics, en funci\u00f3 de <a href=\"https:\/\/www.esmo.org\/Guidelines\/ESMO-MCBS\">l\u2019Escala\nde Magnitud de Benefici Cl\u00ednic d\u2019ESMO<\/a>, una eina desenvolupada per aquesta societat cient\u00edfica europea per\nquantificar el benefici que ofereixen els nous f\u00e0rmacs.<\/p>\n\n\n\n<p>En un d\u2019aquests estudis, realitzat a Fran\u00e7a, els autors van observar que gaireb\u00e9 la meitat dels nous f\u00e0rmacs aprovats entre 2004 i 2017 per al tractament de tumors s\u00f2lids oferien pocs beneficis afegits a l\u2019Escala de Magnitud de Benefici Cl\u00ednic d\u2019ESMO i gaireb\u00e9 dos ter\u00e7os puntuaven baix en una altra escala similar desenvolupada per les autoritats reguladores franceses. De mitjana, els nous compostos tenien un cost 2.525\u20ac superior als seus equivalents per al mateix tipus de c\u00e0ncer. <\/p>\n\n\n\n<p>En una segona an\u00e0lisi, es va realitzar una comparativa similar entre els preus a Europa i els d\u2019EEUU, amb un perfil encara menys favorable en el cas dels preus nord-americans.<\/p>\n\n\n\n<p>Al voltant de 29.000 especialistes en c\u00e0ncer de tot el m\u00f3n s&#8217;han reunit a Barcelona en el Congr\u00e9s anual de la Societat Europea d&#8217;Oncologia M\u00e8dica (ESMO). En aquesta cita s&#8217;han donat a con\u00e8ixer els principals aven\u00e7os terap\u00e8utics en el maneig de diversos tipus de tumors, per\u00f2 que no \u00e9s aliena a la realitat (cada vegada m\u00e9s complexa) que envolta al tractament del c\u00e0ncer, comen\u00e7ant pel cost creixent dels nous f\u00e0rmacs i un \u00fas m\u00e9s racional i sostenible dels recursos, adequant l&#8217;administraci\u00f3 de les ter\u00e0pies a les necessitats reals dels pacients.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dos estudis alerten que els f\u00e0rmacs mes cars no sempre ofereixen un benefici addicional en proporci\u00f3 al seu elevat cost<\/p>\n","protected":false},"author":2313,"featured_media":15599,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2066,10,11,12,13,14,15,2071,32],"tags":[147,1070,1798,1951],"class_list":["post-15592","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-categoria-actualitat","category-empresarials","category-fefac","category-afb","category-afet","category-afell","category-agfe","category-estudis-i-informes","category-estudis","tag-estudis","tag-investigacio","tag-farmac","tag-medicament"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Estudis alerten que f\u00e0rmacs cars no sempre ofereixen benefici addicional<\/title>\n<meta name=\"description\" content=\"Dos estudis alerten que els f\u00e0rmacs mes cars no sempre ofereixen un benefici addicional en proporci\u00f3 al seu elevat cost\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fefac.cat\/empresarial\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Estudis alerten que f\u00e0rmacs cars no sempre ofereixen benefici addicional\" \/>\n<meta property=\"og:description\" content=\"Dos estudis alerten que els f\u00e0rmacs mes cars no sempre ofereixen un benefici addicional en proporci\u00f3 al seu elevat cost\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fefac.cat\/empresarial\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\/\" \/>\n<meta property=\"og:site_name\" content=\"FEFAC\" \/>\n<meta property=\"article:published_time\" content=\"2019-10-04T09:29:01+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-10-04T09:35:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2019\/10\/ESMO-rueda-de-premsa.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"640\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"lclavijo@afb.cat\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"lclavijo@afb.cat\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\\\/\"},\"author\":{\"name\":\"lclavijo@afb.cat\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\"},\"headline\":\"Dos estudis alerten que els f\u00e0rmacs m\u00e9s cars no sempre ofereixen un benefici addicional en proporci\u00f3 al seu elevat cost\",\"datePublished\":\"2019-10-04T09:29:01+00:00\",\"dateModified\":\"2019-10-04T09:35:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\\\/\"},\"wordCount\":409,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2019\\\/10\\\/ESMO-rueda-de-premsa.jpg\",\"keywords\":[\"estudis\",\"investigaci\u00f3\",\"f\u00e0rmac\",\"medicament\"],\"articleSection\":[\"Actualitat\",\"Empresarials\",\"FEFAC\",\"AFB\",\"AFET\",\"AFELL\",\"AGFE\",\"Estudis i informes\",\"Estudis\"],\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\\\/\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\\\/\",\"name\":\"Estudis alerten que f\u00e0rmacs cars no sempre ofereixen benefici addicional\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2019\\\/10\\\/ESMO-rueda-de-premsa.jpg\",\"datePublished\":\"2019-10-04T09:29:01+00:00\",\"dateModified\":\"2019-10-04T09:35:08+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\"},\"description\":\"Dos estudis alerten que els f\u00e0rmacs mes cars no sempre ofereixen un benefici addicional en proporci\u00f3 al seu elevat cost\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\\\/#breadcrumb\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\\\/#primaryimage\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2019\\\/10\\\/ESMO-rueda-de-premsa.jpg\",\"contentUrl\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/wp-content\\\/uploads\\\/2019\\\/10\\\/ESMO-rueda-de-premsa.jpg\",\"width\":1024,\"height\":640},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Dos estudis alerten que els f\u00e0rmacs m\u00e9s cars no sempre ofereixen un benefici addicional en proporci\u00f3 al seu elevat cost\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#website\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/\",\"name\":\"FEFAC\",\"description\":\"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/#\\\/schema\\\/person\\\/6ac15c94fb359972b6bfa9c752486744\",\"name\":\"lclavijo@afb.cat\",\"url\":\"https:\\\/\\\/fefac.cat\\\/empresarial\\\/author\\\/laura-2\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Estudis alerten que f\u00e0rmacs cars no sempre ofereixen benefici addicional","description":"Dos estudis alerten que els f\u00e0rmacs mes cars no sempre ofereixen un benefici addicional en proporci\u00f3 al seu elevat cost","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fefac.cat\/empresarial\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\/","og_locale":"ca_ES","og_type":"article","og_title":"Estudis alerten que f\u00e0rmacs cars no sempre ofereixen benefici addicional","og_description":"Dos estudis alerten que els f\u00e0rmacs mes cars no sempre ofereixen un benefici addicional en proporci\u00f3 al seu elevat cost","og_url":"https:\/\/fefac.cat\/empresarial\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\/","og_site_name":"FEFAC","article_published_time":"2019-10-04T09:29:01+00:00","article_modified_time":"2019-10-04T09:35:08+00:00","og_image":[{"width":1024,"height":640,"url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2019\/10\/ESMO-rueda-de-premsa.jpg","type":"image\/jpeg"}],"author":"lclavijo@afb.cat","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"lclavijo@afb.cat","Temps estimat de lectura":"2 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fefac.cat\/empresarial\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\/#article","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\/"},"author":{"name":"lclavijo@afb.cat","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744"},"headline":"Dos estudis alerten que els f\u00e0rmacs m\u00e9s cars no sempre ofereixen un benefici addicional en proporci\u00f3 al seu elevat cost","datePublished":"2019-10-04T09:29:01+00:00","dateModified":"2019-10-04T09:35:08+00:00","mainEntityOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\/"},"wordCount":409,"commentCount":0,"image":{"@id":"https:\/\/fefac.cat\/empresarial\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2019\/10\/ESMO-rueda-de-premsa.jpg","keywords":["estudis","investigaci\u00f3","f\u00e0rmac","medicament"],"articleSection":["Actualitat","Empresarials","FEFAC","AFB","AFET","AFELL","AGFE","Estudis i informes","Estudis"],"inLanguage":"ca","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/fefac.cat\/empresarial\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/fefac.cat\/empresarial\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\/","url":"https:\/\/fefac.cat\/empresarial\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\/","name":"Estudis alerten que f\u00e0rmacs cars no sempre ofereixen benefici addicional","isPartOf":{"@id":"https:\/\/fefac.cat\/empresarial\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fefac.cat\/empresarial\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\/#primaryimage"},"image":{"@id":"https:\/\/fefac.cat\/empresarial\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\/#primaryimage"},"thumbnailUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2019\/10\/ESMO-rueda-de-premsa.jpg","datePublished":"2019-10-04T09:29:01+00:00","dateModified":"2019-10-04T09:35:08+00:00","author":{"@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744"},"description":"Dos estudis alerten que els f\u00e0rmacs mes cars no sempre ofereixen un benefici addicional en proporci\u00f3 al seu elevat cost","breadcrumb":{"@id":"https:\/\/fefac.cat\/empresarial\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\/#breadcrumb"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fefac.cat\/empresarial\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/fefac.cat\/empresarial\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\/#primaryimage","url":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2019\/10\/ESMO-rueda-de-premsa.jpg","contentUrl":"https:\/\/fefac.cat\/empresarial\/wp-content\/uploads\/2019\/10\/ESMO-rueda-de-premsa.jpg","width":1024,"height":640},{"@type":"BreadcrumbList","@id":"https:\/\/fefac.cat\/empresarial\/estudis-alerten-farmacs-cars-no-sempre-ofereixen-benefici-addicional\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fefac.cat\/empresarial\/"},{"@type":"ListItem","position":2,"name":"Dos estudis alerten que els f\u00e0rmacs m\u00e9s cars no sempre ofereixen un benefici addicional en proporci\u00f3 al seu elevat cost"}]},{"@type":"WebSite","@id":"https:\/\/fefac.cat\/empresarial\/#website","url":"https:\/\/fefac.cat\/empresarial\/","name":"FEFAC","description":"Federaci\u00f3 d&#039;Associacions de Farm\u00e0cies de Catalunya","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fefac.cat\/empresarial\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/fefac.cat\/empresarial\/#\/schema\/person\/6ac15c94fb359972b6bfa9c752486744","name":"lclavijo@afb.cat","url":"https:\/\/fefac.cat\/empresarial\/author\/laura-2\/"}]}},"_links":{"self":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/15592","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/users\/2313"}],"replies":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/comments?post=15592"}],"version-history":[{"count":0,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/posts\/15592\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media\/15599"}],"wp:attachment":[{"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/media?parent=15592"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/categories?post=15592"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fefac.cat\/empresarial\/wp-json\/wp\/v2\/tags?post=15592"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}